UPLOAD Filing
Scinai Immunotherapeutics Ltd.
Date: Sept. 29, 2025 · CIK: 0001611747 · Accession: 0000000000-25-010580
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290437
Letter
Re: Scinai Immunotherapeutics Ltd. Registration Statement on Form F-1 Filed September 22, 2025 File No. 333-290437 Dear Amir Reichman:
September 29, 2025
Amir Reichman Chief Executive Officer Scinai Immunotherapeutics Ltd. Jerusalem BioPark, 2nd Floor Hadassah Ein Kerem Campus Jerusalem, Israel
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Perry Wildes, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 29, 2025 Amir Reichman Chief Executive Officer Scinai Immunotherapeutics Ltd. Jerusalem BioPark, 2nd Floor Hadassah Ein Kerem Campus Jerusalem, Israel Re: Scinai Immunotherapeutics Ltd. Registration Statement on Form F-1 Filed September 22, 2025 File No. 333-290437 Dear Amir Reichman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Perry Wildes, Esq. </TEXT> </DOCUMENT>